✦ LIBER ✦

Efficacy and safety of canagliflozin over 52 weeks in patients with type 2 diabetes on background metformin and pioglitazone

✍ Scribed by Forst, T.; Guthrie, R.; Goldenberg, R.; Yee, J.; Vijapurkar, U.; Meininger, G.; Stein, P.

Book ID: 121709353
Publisher: John Wiley and Sons
Year: 2014
Tongue: English
Weight: 622 KB
Volume: 16
Category: Article
ISSN: 1462-8902
DOI: 10.1111/dom.12273

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and Safety of Canagliflozin (CA

Efficacy and Safety of Canagliflozin (CANA) in Subjects with Type 2 Diabetes Mellitus (T2DM) on Metformin (MET) and Pioglitazone (PIO) Over 52 Weeks

✍ Goldenberg, Ronald; Forst, Thomas; Guthrie, Robert; Yee, Jacqueline; Vijapurkar, 📂 Article 📅 2013 🏛 Canadian Diabetes Association 🌐 English ⚖ 132 KB

Efficacy and safety of canagliflozin com

Efficacy and safety of canagliflozin compared with placebo and sitagliptin in patients with type 2 diabetes on background metformin monotherapy: a randomised trial

✍ Lavalle-González, F. J.; Januszewicz, A.; Davidson, J.; Tong, C.; Qiu, R.; Canov 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 411 KB

Efficacy and Safety of Canagliflozin, a

Efficacy and Safety of Canagliflozin, a Sodium Glucose Co-Transporter 2 Inhibitor, Versus Glimepiride in Patients with Type 2 Diabetes on Background Metformin

✍ Leiter, Lawrence A.; Cefalu, William T.; Niskanen, Leo; Xie, John; Millington, D 📂 Article 📅 2012 🏛 Canadian Diabetes Association 🌐 English ⚖ 62 KB

Efficacy and Safety of Canagliflozin (CA

Efficacy and Safety of Canagliflozin (CANA) in Subjects with Type 2 Diabetes Mellitus (T2DM) and Chronic Kidney Disease (CKD) Over 52 Weeks

✍ Yale, Jean-Francois; Bakris, George; Cariou, Bertrand; Nieto, Javier; Wajs, Ewa; 📂 Article 📅 2013 🏛 Canadian Diabetes Association 🌐 English ⚖ 61 KB

Long-Term Efficacy and Safety of Canagli

Long-Term Efficacy and Safety of Canagliflozin (CANA) in Older Patients with Type 2 Diabetes Mellitus (T2DM) Over 104 Weeks

✍ Harris, Stewart; Bode, Bruce; Stenlöf, Kaj; Sullivan, Daniel; Fung, Albert; Usis 📂 Article 📅 2014 🏛 Canadian Diabetes Association 🌐 English ⚖ 47 KB

Saxagliptin Add-on Therapy to Insulin Wi

Saxagliptin Add-on Therapy to Insulin With or Without Metformin for Type 2 Diabetes Mellitus: 52-Week Safety and Efficacy

✍ Barnett, Anthony H.; Charbonnel, Bernard; Li, Jia; Donovan, Mark; Fleming, Dougl 📂 Article 📅 2013 🏛 Springer International Publishing AG 🌐 English ⚖ 449 KB